Researchers at the University of São Paulo’s Ribeirão Preto School of Pharmaceutical Sciences (FCFRP-USP) in Brazil have found a molecule in the venom of Brotheas amazonicus, a species of scorpion native to the Amazon, which appears to attack breast cancer cells in a way similar to a widely used chemotherapy medication. Their findings were presented…
Menarini and Insilico ink $550M deal for AI-discovered cancer therapy
Second collaboration builds on rapid progress of AI-designed KAT6 inhibitor licensed in 2024 Agreement includes $20 million upfront payment with potential total value exceeding $550 million plus tiered royalties New preclinical asset demonstrates broad anti-tumor activity across multiple solid tumor types Less than a year after their first collaboration, pharmaceutical giant Menarini Group and AI-driven…